Skip to main content

Table 2 Substance use and access to care at prison entry.

From: Harm reduction and equity of access to care for French prisoners: a review

  Mouquet Sahajian Lukasiewicz Oppidum Feuillerat
  1997 (%) 2003 (%) 2003 (%) 2003–2004 (%) 2005 (%) 1998 (%) 2001 (%) 2004 (%)
Method :         
   Number of prisons, inmates 135 prisons 134 prisons 3 prisons 23 prisons 9 prisons All prisons
  8 728 files 6 087 files 1 463 files 998 inmates 215 questionnaires Questionnaires to medical staff
   Population Incoming inmates, Incoming inmates, Incoming inmates Cross sectional study Stratified random sample Drug users' sample self-questionnaire All inmates
   Study period 1 month from 2 weeks to 3 months depending of the size of the prison 1 year    1 week
   diagnosis Regular, extended drug use previous 12 months Regular, extended drug use previous 12 months Regular use, abuse or dependence during previous 6 months DSM-IV criteria for drug abuse or dependence, including cannabis     
1. Heroin, morphine, opium use 14.4 6.5    15    
2. Cocaine/crack use 8.9 7.7 4.1 [1+2+3] 27.9 [1+2+3+ cannabis use] 26    
3. Other drugs (LSD, ecstasy) 3.4 4.0       
4. Psychotropic drugs use 9.1 5.4 2.5   67    
5. Polydrug use 14.6 10.5 29   65    
6. Intravenous drug use 6.2 2.6    10    
7. History of drug injection 11.8 6.5       
8. Methadone at prison entry 0.6 1.5    22    
9. Buprenorphine at prison entry 6.3 6.0    78    
10. OST at prison entry* or during prison stay** 6.9* 7.5* 11*   56* 2.0** 5.4** 6.6**